The debt of ABBOTT LABORATORIES over the past 10 years
Chart ABBOTT LABORATORIES: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, ABBOTT LABORATORIES had liquid cash of $8.94B and total debt of $12.93B: net debt of $3.99B. It had more debt than liquid cash at all 10 year-ends shown. Total debt was highest at the end of fiscal 2017 ($27.92B) and lowest at the end of fiscal 2025 ($12.93B).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $8.94B* | $12.93B | -$3.99B |
| 2024ended Dec 31, 2024 | $7.97B* | $14.13B | -$6.16B |
| 2023ended Dec 31, 2023 | $7.28B* | $14.68B | -$7.4B |
| 2022ended Dec 31, 2022 | $10.17B* | $16.77B | -$6.6B |
| 2021ended Dec 31, 2021 | $10.25B* | $18.05B | -$7.8B |
| 2020ended Dec 31, 2020 | $7.15B* | $18.75B | -$11.6B |
| 2019ended Dec 31, 2019 | $4.14B* | $18.14B | -$14B |
| 2018ended Dec 31, 2018 | $4.09B* | $19.57B | -$15.48B |
| 2017ended Dec 31, 2017 | $9.61B* | $27.92B | -$18.31B |
| 2016ended Dec 31, 2016 | $18.77B* | $22.01B | -$3.23B |
Fiscal years as ABBOTT LABORATORIES reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ABBOTT LABORATORIES
- The revenue of ABBOTT LABORATORIES
- The profitability of ABBOTT LABORATORIES
- The cash flow of ABBOTT LABORATORIES
- The dividends of ABBOTT LABORATORIES
- All of ABBOTT LABORATORIES's financials, charted
Companies of a similar size
Not investment advice. This page shows what ABBOTT LABORATORIES filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.